| Avalide Dosages & Strengths | ||||
|---|---|---|---|---|
| Strength | Format | Route | Strength | Class |
| Avalide 12.5 mg-300 mg | tablet | oral | 1.0 each | OTC |
| Avalide 25 mg-300 mg | tablet | oral | 1.0 each | OTC |
| Avalide 25 mg-300 mg | tablet | oral | 1.0 each | OTC |
| Avalide 12.5 mg-150 mg | tablet | oral | 1.0 each | OTC |
Posted by lisarose about 1 year ago
Shortness of breath...hard to take a deep breath, anxiety, pounding/rapid heart rate. Out of breath when walking and muscles weakness. I want to lay down. I am OFF this med..like now..
Posted by shedeedn about 1 year ago
I'm on avalide and zoloft. For about a year, shortly after I started taking avalide my legs started hurting. The doctors have taken x-rays of my back and an MRI but can't figure out my legs. Also I can't sleep at night so i take ambien. HELP!
signed
Too young for this
Posted by ass over 2 years ago
after 4 days of use, systolic pressure at 120 (was 180), diastolic pressure 95 (was 121). As soon as systolic got to "normal" became profoundly suicidally depressed.
Bristol-Myers Squibb Company Reports Financial Results for the ... - PR Newswire (press release)
2006 Twelve Months Ended December 31, Pharmaceuticals Cardiovascular Plavix $4755 $3257 46 % 4060 2655 53 % 34 % Avapro/Avalide 1204 1097 10 % 692 647 7 ...
Thu Jan 31 09:05:57 +0000 2008
Bristol-Myers Squibb Company Reports Financial Results for the ... - PR Newswire (press release)
2006 Twelve Months Ended December 31, Pharmaceuticals Cardiovascular Plavix $4755 $3257 46 % 4060 2655 53 % 34 % Avapro/Avalide 1204 1097 10 % 692 647 7 ...
Thu Jan 31 07:34:14 +0000 2008
Bristol-Myers Squibb Company Reports Financial Results for the ... - CNNMoney.com
2006 Twelve Months Ended December 31, Pharmaceuticals Cardiovascular Plavix $4755 $3257 46 % 4060 2655 53 % 34 % Avapro/Avalide 1204 1097 10 % 692 647 7 ...
Thu Jan 31 07:37:26 +0000 2008
hydrochlorothiazide - The hydrogenated derivative of chlorothiazide, a thiazide diuretic with antihypertensive and anti-urolithic effects. This agent binds to the electroneutral Na-K-Cl cotransporter (NKCC) and thereby impairs Na+, K+ and Cl- reabsorption on the luminal membrane of the early segment in the distal convoluted tubule in the kidney. This leads to an increase in urinary excretion of sodium, chloride, potassium, bicarbonate and water subsequently reducing plasma and extracellular fluid volume leading to a reduction in blood pressure. Hydrochlorothiazide also decreases urinary calcium and uric acid excretion by direct action on the distal tubule.
irbesartan - A nonpeptide angiotensin II antagonist with antihypertensive activity. Irbesartan selectively and competitively blocks the binding of angiotensin II to the angiotensin I receptor. Angiotensin II stimulates aldosterone synthesis and secretion by adrenal cortex, which decreases the excretion of sodium and increases the excretion of potassium. Angiotensin II also acts as a vasoconstrictor in vascular smooth muscle. (NCI05)